Literature DB >> 1928482

Effect of fluoxetine on patients with multiple sclerosis.

J W Flax, J Gray, J Herbert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1928482     DOI： 10.1176/ajp.148.11.1603a

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  4 in total

1.  A randomized placebo-controlled trial of duloxetine for central pain in multiple sclerosis.

Authors:  Theodore R Brown; April Slee
Journal:  Int J MS Care       Date:  2015 Mar-Apr

Review 2.  Therapeutic potential of fluoxetine in neurological disorders.

Authors:  Jop P Mostert; Marcus W Koch; Marco Heerings; Dorothea J Heersema; Jacques De Keyser
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

Review 3.  Neuropsychiatric syndromes associated with multiple sclerosis.

Authors:  Anthony Feinstein
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

Review 4.  Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015-2020.

Authors:  Niklas Huntemann; Leoni Rolfes; Marc Pawlitzki; Tobias Ruck; Steffen Pfeuffer; Heinz Wiendl; Sven G Meuth
Journal:  Drugs       Date:  2021-06-04       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.